Printer Friendly

Zosano Pharma hires Joseph P. Hagan to board.

M2 EQUITYBITES-May 28, 2015-Zosano Pharma hires Joseph P. Hagan to board

(C)2015 M2 COMMUNICATIONS http://www.m2.com

Pharmaceutical company Zosano Pharma (NasdaqCM:ZSAN) revealed on Wednesday that Joseph "Jay" P. Hagan has joined its board of directors, with effect from 22 May 2015.

Currently, Hagan serves as executive vice president, chief business & financial officer of Orexigen Therapeutics (NasdaqGS:OREX), a public biotechnology company, since 2011. Recently, he has served as Orexigen's senior vice president, Corporate Development, Strategy and Communications from May 2009 to June 2011.

Previously, Hagan was employed at Amgen in various senior business development roles, including founder and managing director of Amgen Ventures as well as head of corporate development at Amgen, leading the acquisitions of Immunex and Tularik and the spinouts of Novantrone and Relypsa.

In the past, Hagan has worked for five years in the bioengineering labs at Genzyme and Advanced Tissue Sciences.

((Comments on this story may be sent to info@m2.com))

COPYRIGHT 2015 Normans Media Ltd.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2015 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:M2 EquityBites (EQB)
Date:May 28, 2015
Words:160
Previous Article:Actavis wins US FDA approval for VIBERZI for treating adults suffering from irritable bowel syndrome with diarrhea (IBS-D).
Next Article:Jernigan Capital names John A Good as president and COO.

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters